Xeris Pharmaceuticals | XERS - Stock


Xeris Pharmaceuticals reported $67.46M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Celltrion KRW 2.71T 121.94B Jun/2025
Cspc Pharmaceutical CNY 2.87B 259.23M Jun/2025
Divis Laboratories Ltd INR 32.36B 910M Mar/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Kangmei Pharma CNY 2.45B 12.27M Sep/2025
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Laboratorios Farma EUR 327.67M 2.28M Jun/2025
Medical Developments International AUD 9.45M 679K Jun/2025
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Organigram Holdings CAD 123.95M 1.24M Sep/2025
Pacira USD 152.86M 4.82M Dec/2025
Perrigo USD 1.15B 78M Dec/2025
Pharma Mar EUR 49.5M 1.02M Jun/2025
Qiagen NV USD 290.23M 2.32M Sep/2025
Sartorius EUR 827.9M 30.5M Sep/2025
Sino Biopharmaceutical CNY 1.84B 156.17M Jun/2024
Supernus Pharmaceuticals USD 107.1M 63.08M Sep/2025
Tilray USD 282.79M 11.9M Jun/2025
Zz Pientze Pharmaceu CNY 5.72B 778.27M Jun/2025